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Background
One of the major challenges in the development of an
effective HIV-1 vaccine is the extraordinary genetic diver-
sity of the virus. Immunizations of nonhuman primates
using consensus and mosaic immunogens have been
shown to elicit cross-reactive CD8+T lymphocyte
responses that increase the depth of epitope recognition.
However, one of the limitations of vaccine-induced epi-
tope-specific CD8+T lymphocytes includes lack of protec-
tion against diverse strains and emergent forms of HIV-1
due to altered T cell receptor (TCR) affinity for variant
peptide:MHC class I complexes.
Methods
In this study, we immunized a cohort of fifteen Mamu-
A*01+ rhesus monkeys with either a 3-valent mosaic
Env, group M consensus Env, or single clade B Env vac-
cine and compared the ability of the CD8+T lymphocyte
populations elicited by each immunogen to recognize
variants of an HIV-1 envelope epitope sequence p41A
(YI9). We identified vaccine-induced CD8+T lympho-
cytes populations using tetramers constructed with 9 var-
iants of p41A epitope. We assessed the ability of those
variant peptides to activate CTL by measuring cytokine
production and CD107a expression. We evaluated prolif-
eration using carboxyfluorescein succinimidyl ester.
Finally, we investigated the functional avidity of these
CD8+T lymphocytes for the variant peptide:Mamu-A*01
complexes using surface plasmon resonance technology.
Results
Our data show that Env immunizations can generate
cross-reactive CD8+T lymphocytes that recognize 2 of 9
(22%) of the variants of p41A epitope, with higher
responses induced by the consensus and the 3-valent
mosaic immunogens (variant from clade C and variant
from clade A/E) compared to the single clade Env immu-
nogen. Tetramer-binding data also show that CD8+
T lymphocytes from monkeys immunized with mosaic
immunogen have a trend of higher binding to majority of
the variant peptides tested.
Conclusion
This underscores the potential of mosaic immunogens
for generating cellular immune responses with greater
depth.
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